Abstract
Background Inferior alveolar nerve block is the most frequently used local anesthetic agent, administered to achieve regional anesthesia for root canal treatment, however, in cases of irreversible pulpitis, there may be anesthetic resistance. To overcome this issue, many conservative and invasive supplementary procedures are introduced to increase the efficacy of nerve block, including prophylactic use of orally administered NSAIDs.
Objective To compare the effect of prophylactically administered Ketorolac and Diclofenac Potassium on the efficacy of inferior alveolar nerve block in patients presenting with symptomatic irreversible pulpitis.
Methodology This double-blind study included a total number of 130 patients with a diagnosis of symptomatic irreversible pulpitis which was confirmed with a cold test. Before initiating the treatment, the patients were asked to rate their pain on a VAS with pain divided into four categories, no pain, mild pain, moderate pain, and severe pain. 10 mg Ketorolac and 50 mg Diclofenac potassium were equally divided into two groups and 1 tablet of each was orally administered to patients 1 hour before initiating root canal treatment. IANB was given and a root canal procedure was initiated under full aseptic protocol. The pain score was recorded on VAS during endodontic access preparation and root canal instrumentation. Data was analyzed through cross-tabulation and the Chi-square test was applied. (P value = 0.05)
Results The comparison of prophylactically administered ketorolac and diclofenac potassium on the efficacy of inferior alveolar nerve block depicted the success rate was 64.6% in Ketorolac group as compared to 43.1% in Diclofenac potassium group.
Conclusion Oral premedication with NSAIDs can improve the efficacy of Inferior alveolar nerve block in a non-invasive manner with better results yielded with the use of orally administered Ketorolac as compared to Diclofenac Potassium.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
ACTRN12622000633785
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee/IRB of Armed Forces Institute of Dentistry, Rawalpindi, Pakistan gave ethical approval for this work
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
